BTAI - BioXcel Therapeutics, Inc.
1.53
-0.050 -3.268%
Share volume: 72,945
Last Updated: 05-09-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.09%
PREVIOUS CLOSE
CHG
CHG%
$1.58
-0.05
-0.03%
Summary score
30%
Profitability
25%
Dept financing
6%
Liquidity
50%
Performance
35%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-21.67%
Return on assets
-17.69%
Return on sales
0%
Return on invested capital
168.33%
Total debt ratio
15.85%
Debt ratio change over timeo
0%
Current Ratio
11.24%
Quick Ratio
0%
Cash Position Ratio
11%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-29.41%
Return on assets
-22.98%
Return on sales
0%
Return on invested capital
147.17%
Total debt ratio
21.74%
Debt ratio change over timeo
0%
Current Ratio
5.03%
Quick Ratio
0%
Cash Position Ratio
4.83%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-40.11%
Return on assets
-30.42%
Return on sales
0%
Return on invested capital
152.86%
Total debt ratio
24.22%
Debt ratio change over time
0%
Current Ratio
4.23%
Quick Ratio
0%
Cash Position Ratio
4.05%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | BTAI | LLY | JNJ | NVO |
|---|---|---|---|---|
| Return on equity | -21.67% | 17.45% | 4.69% | 19.89% |
| Return on assets | -17.69% | 3.37% | 3.35% | 11.41% |
| Return on sales | 0% | 23.96% | 25.96% | 42.05% |
| Return on invested capital | 168.33% | 5.2% | 4.37% | -272.99% |
| Profitability | 25% | 44% | 29% | 75% |
| Total debt ratio | 15.85% | 77% | 57.66% | 53.92% |
| Debt ratio change over time | 0% | 0% | 10.55% | 0% |
| Dept financing | 5% | 25% | 44% | 18% |
| Current Ratio | 5.03% | 1.16% | 1.27% | 1.05% |
| Quick Ratio | 0% | 0.89% | 1.01% | 0.77% |
| Cash Position Ratio | 4.83% | 0.17% | 0.53% | 0.31% |
| Liquididy | 50% | 23% | 30% | 19% |
| Short-term ratios | BTAI | LLY | JNJ | NVO |
|---|---|---|---|---|
| Return on equity | -29.41% | 44.06% | 6.24% | 17.3% |
| Return on assets | -22.98% | 3.88% | 3.22% | 9.33% |
| Return on sales | 0% | 27.04% | 24.93% | 40.02% |
| Return on invested capital | 147.17% | 9.69% | 4.96% | -224.06% |
| Profitability | 25% | 54% | 29% | 60% |
| Total debt ratio | 21.74% | 91.8% | 61.39% | 55.88% |
| Debt ratio change over time | 0% | 0% | 12.93% | 0% |
| Dept financing | 6% | 25% | 42% | 15% |
| Current Ratio | 5.03% | 1.16% | 1.27% | 1.05% |
| Quick Ratio | 0% | 0.89% | 1.01% | 0.77% |
| Cash Position Ratio | 4.83% | 0.17% | 0.53% | 0.31% |
| Liquididy | 50% | 29% | 34% | 26% |
